zalcitabine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eshita, Y; Ji, RC; Kobayashi, T; Kubota, N; Mizuno, M; Onishi, M; Onishi, Y; Yoshida, J | 1 |
| Bieth, A; Cazaux, C; Hoffmann, JS; Louat, T; Rols, MP; Servant, L; Teissie, J | 1 |
2 other study(ies) available for zalcitabine and B16 Melanoma
| Article | Year |
|---|---|
A robust control system for targeting melanoma by a supermolecular DDMC/paclitaxel complex.
Topics: Allosteric Site; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DEAE-Dextran; Female; Humans; Kinetics; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Particle Size; Signal Transduction; Tumor Microenvironment; Zalcitabine | 2018 |
Antitumor activity of 2',3'-dideoxycytidine nucleotide analog against tumors up-regulating DNA polymerase beta.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Extracts; Cell Survival; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA; DNA Polymerase beta; Enzyme Activation; Melanoma, Experimental; Mice; Neoplasm Transplantation; Simian virus 40; Tumor Cells, Cultured; Up-Regulation; Virus Replication; Zalcitabine | 2001 |